These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33411680)

  • 1. Overexpression of long noncoding RNA ANRIL inhibits phenotypic switching of vascular smooth muscle cells to prevent atherosclerotic plaque development
    Hu DJ; Li ZY; Zhu YT; Li CC
    Aging (Albany NY); 2020 Dec; 13(3):4299-4316. PubMed ID: 33411680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability.
    Ding Y; Zhang M; Zhang W; Lu Q; Cai Z; Song P; Okon IS; Xiao L; Zou MH
    Circ Res; 2016 Sep; 119(6):718-30. PubMed ID: 27439892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway.
    Shi X; Zhang Y; Han J; Peng W; Fang Z; Qin Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y
    J Cardiovasc Pharmacol; 2021 May; 77(5):642-649. PubMed ID: 33951699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE
    Li D; Chen A; Lan T; Zou Y; Zhao L; Yang P; Qu H; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    FASEB J; 2019 Mar; 33(3):3437-3450. PubMed ID: 30462530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway.
    Li S; Shi Y; Liu P; Song Y; Liu Y; Ying L; Quan K; Yu G; Fan Z; Zhu W
    J Neuroinflammation; 2020 Jun; 17(1):191. PubMed ID: 32546267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of long non-coding RNA ANRIL promotes post-ischaemic angiogenesis and improves cardiac functions by targeting Akt.
    Huang Q; Pan M; Zhou JP; Yin F
    J Cell Mol Med; 2020 Jun; 24(12):6860-6868. PubMed ID: 32400082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Suppresses the Progress of Diabetes-Accelerated Atherosclerosis by Inhibition of Vascular Smooth Muscle Cell Migration Through AMPK-Pdlim5 Pathway.
    Yan Y; Li T; Li Z; He M; Wang D; Xu Y; Yang X; Bai Y; Lao Y; Zhang Z; Wu W
    Front Cardiovasc Med; 2021; 8():690627. PubMed ID: 34368251
    [No Abstract]   [Full Text] [Related]  

  • 9. Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway.
    Sung JY; Kim SG; Park SY; Kim JR; Choi HC
    Exp Mol Med; 2024 Sep; 56(9):1967-1979. PubMed ID: 39223261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway.
    Yang JJ; Yang Y; Zhang C; Li J; Yang Y
    J Cell Mol Med; 2020 Feb; 24(4):2677-2687. PubMed ID: 31961061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
    Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
    Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MRAK048635_P1 is critical for vascular smooth muscle cell function and phenotypic switching in essential hypertension.
    Fang G; Qi J; Huang L; Zhao X
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a/Sirt1.
    Tan P; Guo YH; Zhan JK; Long LM; Xu ML; Ye L; Ma XY; Cui XJ; Wang HQ
    Biochem Cell Biol; 2019 Oct; 97(5):571-580. PubMed ID: 30789795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase.
    Seneviratne A; Cave L; Hyde G; Moestrup SK; Carling D; Mason JC; Haskard DO; Boyle JJ
    Cardiovasc Res; 2021 Apr; 117(5):1295-1308. PubMed ID: 32667970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA RP4-639F20.1 interacts with THRAP3 to attenuate atherosclerosis by regulating c-FOS in vascular smooth muscle cells proliferation and migration.
    Zhang R; Bu F; Wang Y; Huang M; Lin X; Wu C; Chen J; Huang Y; Wang H; Ye S; Hu X; Wang Q; Zheng L
    Atherosclerosis; 2023 Aug; 379():117183. PubMed ID: 37549548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA
    You G; Long X; Song F; Huang J; Tian M; Xiao Y; Deng S; Wu Q
    Drug Des Devel Ther; 2020; 14():457-468. PubMed ID: 32099330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway.
    Kang CM; Li WK; Yu KW; Li XH; Huang RY; Ke PF; Jin X; Cao SW; Yuan YS; Wang H; Yan J; Chen WY; Huang XZ; Zhao JJ
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34608503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of astragaloside IV-inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5-mediated ERK signaling.
    Song Z; Wei D; Chen Y; Chen L; Bian Y; Shen Y; Chen J; Pan Y
    Toxicol Appl Pharmacol; 2019 Feb; 364():45-54. PubMed ID: 30529164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
    Osman I; Segar L
    Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.